We have developed and set up several strategies to maximize the transfer of knowledge and technology.
Industrially relevant inventions arising from the institute’s research are identified and protected as industrial property; subsequently they are valorised to a stage where they can be licensed to an industry or a spin-off company.
Moreover, the institute actively pursues the establishment of contract research projects between companies and ICIQ’s research groups, which take advantage of the group’s research expertise.
Large collaborative research projects between an industry and the ICIQ (joint units) have been set up with several companies: AiCuris, Esteve (until June 2020) and Henkel (until March 2019). These projects involve a dedicated laboratory and take advantage of ICIQ group leaders’ assessment and of ICIQ’s state-of-the- art instrumentation facilities.
Finally, ICIQ has created three technology development units: Crysforma, CSOL and ERTFLOW. These units combine a profound scientific knowledge with state-of-the-art instrumentation to respond to specific industrial needs. Crysforma gives scientific and technological support in the field of pharmaceutical solid state development; CSOL is oriented to commercially exploit the diverse catalyst libraries and catalyst know-how developed at the institute, and ERTFLOW develops proprietary technologies related to catalysis and flow chemistry.
